Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS - THERAPEUTIC USE , . Treffer: 263

2019

Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691
Web of Science PubMed FullText FullText_MUG

 

Ferrari, S; Bielack, SS; Smeland, S; Longhi, A; Egerer, G; Sundby Hall, K; Donati, D; Kevric, M; Brosjö, O; Comandone, A; Werner, M; Monge, O; Palmerini, E; Berdel, WE; Bjerkehagen, B; Paioli, A; Lorenzen, S; Eriksson, M; Gambarotti, M; Tunn, PU; Jebsen, NL; Cesari, M; von Kalle, T; Ferraresi, V; Schwarz, R; Bertulli, R; Kasparek, AK; Grignani, G; Krasniqi, F; Sorg, B; Hecker-Nolting, S; Picci, P; Reichardt, P EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2017; 104(1):30-36
Web of Science PubMed FullText FullText_MUG

 

Hann, A; Bohle, W; Egger, J; Zoller, W Feasibility of alternating induction and maintenance chemotherapy in pancreatic cancer.
Sci Rep. 2017; 7(8):41549-41549 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Longhi, A; Bielack, SS; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, AH; Klenke, FM; Grignani, G; Donati, DM; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; Willegger, M; Scoccianti, G; Ferrari, S Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
Eur J Cancer. 2017; 74(1):9-16 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mairinger, FD; Vollbrecht, C; Flom, E; Christoph, DC; Schmid, KW; Kollmeier, J; Popper, HH; Mairinger, T; Walter, RFH Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Oncotarget. 2017; 8(23):37502-37510 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pleyer, L; Döhner, H; Dombret, H; Seymour, JF; Schuh, AC; Beach, CL; Swern, AS; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl Spandl, S; Zebisch, A; Pichler, A; Pfeilstöcker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci. 2017; 18(2): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schramm, A; Schochter, F; Friedl, TWP; de Gregorio, N; Andergassen, U; Alunni-Fabbroni, M; Trapp, E; Jaeger, B; Heinrich, G; Camara, O; Decker, T; Ober, A; Mahner, S; Fehm, TN; Pantel, K; Fasching, PA; Schneeweiss, A; Janni, W; Rack, BK; SUCCESS Study Group Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer. 2017; 17(4):279-285
Web of Science PubMed FullText FullText_MUG

 

2016

Bonin, S; Donada, M; Bussolati, G; Nardon, E; Annaratone, L; Pichler, M; Chiaravalli, AM; Capella, C; Hoefler, G; Stanta, G A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
Tumour Biol. 2016; 37(6):7295-7303
Web of Science PubMed FullText FullText_MUG

 

Rack, B; Jückstock, J; Trapp, E; Weissenbacher, T; Alunni-Fabbroni, M; Schramm, A; Widschwendter, P; Lato, K; Zwingers, T; Lorenz, R; Tesch, H; Schneeweiss, A; Fasching, P; Mahner, S; Beckmann, MW; Lichtenegger, W; Janni, W; SUCCESS Study Group CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Tumour Biol. 2016; 37(10):13769-13775
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Friedl, TW; Schochter, F; Scholz, C; de Gregorio, N; Huober, J; Rack, B; Trapp, E; Alunni-Fabbroni, M; Müller, V; Schneeweiss, A; Pantel, K; Meier-Stiegen, F; Hartkopf, A; Taran, FA; Wallwiener, D; Janni, W; Fehm, T Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet. 2016; 293(2):271-281
Web of Science PubMed FullText FullText_MUG

 

von Bueren, AO; Kortmann, RD; von Hoff, K; Friedrich, C; Mynarek, M; Müller, K; Goschzik, T; Zur Mühlen, A; Gerber, N; Warmuth-Metz, M; Soerensen, N; Deinlein, F; Benesch, M; Zwiener, I; Kwiecien, R; Faldum, A; Bode, U; Fleischhack, G; Hovestadt, V; Kool, M; Jones, D; Northcott, P; Kuehl, J; Pfister, S; Pietsch, T; Rutkowski, S Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
J Clin Oncol. 2016; 34(34):4151-4160
Web of Science PubMed FullText FullText_MUG

 

2015

Benesch, M; Lackner, H; Pilhatsch, A; Gürtl-Lackner, B; Schwinger, W; Urban, C Long-term Remission in a Female With Multiple Relapsed Juvenile Granulosa Cell Tumor.
J Pediatr Hematol Oncol. 2015; 37(8):e486-e489 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Bossuyt, V; Provenzano, E; Symmans, WF; Boughey, JC; Coles, C; Curigliano, G; Dixon, JM; Esserman, LJ; Fastner, G; Kuehn, T; Peintinger, F; von Minckwitz, G; White, J; Yang, W; Badve, S; Denkert, C; MacGrogan, G; Penault-Llorca, F; Viale, G; Cameron, D; Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
ANN ONCOL. 2015; 26(7): 1280-1291. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fastner, G; Reitsamer, R; Ziegler, I; Zehentmayr, F; Fussl, C; Kopp, P; Peintinger, F; Greil, R; Fischer, T; Deutschmann, H; Sedlmayer, F IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Int J Cancer. 2015; 136(5): 1193-1201. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fitzal, F; Filipits, M; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Dubsky, P; Bartsch, R; Kronenwett, R; Gnant, M The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Br J Cancer. 2015; 112(8):1405-1410 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gakis, G; Morgan, TM; Daneshmand, S; Keegan, KA; Todenhöfer, T; Mischinger, J; Schubert, T; Zaid, HB; Hrbacek, J; Ali-El-Dein, B; Clayman, RH; Galland, S; Olugbade, K; Rink, M; Fritsche, HM; Burger, M; Chang, SS; Babjuk, M; Thalmann, GN; Stenzl, A; Efstathiou, JA Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Ann Oncol. 2015; 26(8):1754-1759 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Knauer, M; Moik, M; Jakesz, R; Seifert, M; Taucher, S; Bjelic-Radisic, V; Balic, M; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Selim, U; Fitzal, F; Hochreiner, G; Wette, V; Sevelda, P; Ploner, F; Bartsch, R; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Ann Oncol. 2015; 26(2):313-320 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kaczirek, K; Ciuleanu, TE; Vrbanec, D; Marton, E; Messinger, D; Liegl-Atzwanger, B; Wrba, F; Knittelfelder, R; Lindner, E; Zielinski, CC; Streubel, B; Brodowicz, T FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.
Clin Colorectal Cancer. 2015; 14(2):91-98
Web of Science PubMed FullText FullText_MUG

 

Lamm, W; Wohlfarth, P; Bojic, M; Schörgenhofer, C; Drach, J; Gisslinger, H; Worel, N; Schiefer, A; Schulenburg, A; Agis, H; Kalhs, P; Greinix, HT; Schellongowski, P; Rabitsch, W Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experience.
Oncology. 2015; 89(4): 196-204.
Web of Science PubMed FullText FullText_MUG

 

Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Schlick, K; Huemer, F; Deutsch, A; Neumeister, P; Greil, R; Pichler, M; Egle, A Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
J Natl Compr Canc Netw. 2015; 13(12):1501-1508 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pircher, M; Mlineritsch, B; Fridrik, MA; Dittrich, C; Lang, A; Petru, E; Weltermann, A; Thaler, J; Hufnagl, C; Gampenrieder, SP; Rinnerthaler, G; Ressler, S; Ulmer, H; Greil, R Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.
Anticancer Res. 2015; 35(1):517-521
Web of Science PubMed

 

Troppan, KT; Melchardt, T; Deutsch, A; Schlick, K; Stojakovic, T; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Egle, A; Pichler, M The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Eur J Haematol. 2015; 95(6):538-544
Web of Science PubMed FullText FullText_MUG

 

Volgger, B; Zeimet, AG; Reinthaller, A; Petru, E; Schauer, C; Klein, M; Sevelda-Schwarzgruber, U; Bogner, G; Wolfram, G; Marth, C Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
Int J Gynecol Cancer. 2015; 25(2):257-262 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zhao, Q; Kretschmer, N; Bauer, R; Efferth, T Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib.
Int J Cancer. 2015; 137(6):1446-1456
Web of Science PubMed FullText FullText_MUG

 

2014

Aigner, B; Bauernhofer, T; Petru, E; Niederkorn, A; Arzberger, EJ; Richtig, E Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.
Dermatology. 2014; 229(4):288-292 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Apalla, Z; Lallas, A; Tzellos, T; Sidiropoulos, T; Lefaki, I; Trakatelli, M; Sotiriou, E; Lazaridou, E; Evangelou, G; Patsatsi, A; Kyrgidis, A; Stratigos, A; Zalaudek, I; Argenziano, G; Ioannides, D Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma.
Br J Dermatol. 2014; 170(4):809-815 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Aurer, I; Bašić-Kinda, S; Radman, I; Ilić, I; Grah, JJ Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).
Ann Hematol. 2014; 93(1):177-178 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Ediebah, DE; Coens, C; Zikos, E; Quinten, C; Ringash, J; King, MT; Schmucker von Koch, J; Gotay, C; Greimel, E; Flechtner, H; Weis, J; Reeve, BB; Smit, EF; Taphoorn, MJ; Bottomley, A Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Br J Cancer. 2014; 110(10):2427-2433 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Eisterer, W; De Vries, A; Öfner, D; Rabl, H; Koplmüller, R; Greil, R; Tschmelitsch, J; Schmid, R; Kapp, K; Lukas, P; Sedlmayer, F; Höfler, G; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group (ABCSG) Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Anticancer Res. 2014; 34(11):6767-6773
Web of Science PubMed FullText

 

Goldinger, SM; Zimmer, L; Schulz, C; Ugurel, S; Hoeller, C; Kaehler, KC; Schadendorf, D; Hassel, JC; Becker, J; Hauschild, A; Dummer, R; Dermatology Cooperative Oncology Group (DeCOG) Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients.
Eur J Cancer. 2014; 50(2):406-410
Web of Science PubMed FullText FullText_MUG

 

Hopfinger, G; Nösslinger, T; Lang, A; Linkesch, W; Melchardt, T; Weiss, L; Egle, A; Greil, R Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Ann Hematol. 2014; 93(3):459-462
Web of Science PubMed FullText FullText_MUG

 

Ludwig, H; Kasparu, H; Leitgeb, C; Rauch, E; Linkesch, W; Zojer, N; Greil, R; Seebacher, A; Pour, L; Weißmann, A; Adam, Z Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Blood. 2014; 123(7):985-991 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mian, M; Wasle, I; Gamerith, G; Mondello, P; Melchardt, T; Jäger, T; Linkesch, W; Fiegl, M R-CHOP versus R-COMP: are they really equally effective?
Clin Oncol (R Coll Radiol). 2014; 26(10):648-652
Web of Science PubMed FullText FullText_MUG

 

Niederkorn, A; Wackernagel, W; Artl, M; Schwantzer, G; Aigner, B; Richtig, E Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
Acta Ophthalmol. 2014; 92(8):e696-e697 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ning, Y; Gerger, A; Zhang, W; Hanna, DL; Yang, D; Winder, T; Wakatsuki, T; Labonte, MJ; Stintzing, S; Volz, N; Sunakawa, Y; Stremitzer, S; El-Khoueiry, R; Lenz, HJ Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.
Mol Cancer Ther. 2014; 13(2):528-539 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pircher, A; Gamerith, G; Amann, A; Reinold, S; Popper, H; Gächter, A; Pall, G; Wöll, E; Jamnig, H; Gastl, G; Wolf, AM; Hilbe, W; Wolf, D Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.
Lung Cancer. 2014; 85(1): 81-87.
Web of Science PubMed FullText FullText_MUG

 

Pircher, A; Manzl, C; Fiegl, M; Popper, H; Pirker, R; Hilbe, W Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient.
Lung Cancer. 2014; 83(3): 408-410. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Rabitsch, W; Böhm, A; Bojic, M; Schellongowski, P; Wöhrer, S; Sliwa, T; Keil, F; Worel, N; Greinix, H; Hauswirth, A; Kalhs, P; Jaeger, U; Valent, P; Sperr, WR Clofarabine/cyclophosphamide for debulking before stem cell transplantation.
Eur J Clin Invest. 2014; 44(8):775-783
Web of Science PubMed FullText FullText_MUG

 

Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Grogan, T; Elashoff, D; Geist, C; Silverman, DH; Phelps, ME; Chen, W Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Clin Cancer Res. 2014; 20(13):3550-3559 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, E; Trojan, A; Schuster, SJ; Haybaeck, J Progressive multifocal leukoencephalopathy--a case report and review of the literature.
In Vivo. 2014; 28(5):941-948 (- Case Report)
Web of Science PubMed

 

Steger, GG; Greil, R; Lang, A; Rudas, M; Fitzal, F; Mlineritsch, B; Hartmann, BL; Bartsch, R; Melbinger, E; Hubalek, M; Stoeger, H; Dubsky, P; Ressler, S; Petzer, AL; Singer, CF; Muss, C; Jakesz, R; Gampenrieder, SP; Zielinski, CC; Fesl, C; Gnant, M Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
ANN ONCOL. 2014; 25(2): 366-371. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Troppan, KT; Schlick, K; Deutsch, A; Melchardt, T; Egle, A; Stojakovic, T; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Pichler, M C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Br J Cancer. 2014; 111(1):55-60 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Aigner, B; Plötz, SG; Schaller, G Triple-negative breast cancer possibly transforming into malignant melanoma due to targeted therapy? A case report and review of literature.
Wien Med Wochenschr. 2013; 163(21-22): 495-498. (- Case Report)
PubMed FullText FullText_MUG

 

Batchelor, TT; Mulholland, P; Neyns, B; Nabors, LB; Campone, M; Wick, A; Mason, W; Mikkelsen, T; Phuphanich, S; Ashby, LS; Degroot, J; Gattamaneni, R; Cher, L; Rosenthal, M; Payer, F; Jürgensmeier, JM; Jain, RK; Sorensen, AG; Xu, J; Liu, Q; van den Bent, M Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
J Clin Oncol. 2013; 31(26):3212-3218 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dubsky, P; Filipits, M; Jakesz, R; Rudas, M; Singer, CF; Greil, R; Dietze, O; Luisser, I; Klug, E; Sedivy, R; Bachner, M; Mayr, D; Schmidt, M; Gehrmann, MC; Petry, C; Weber, KE; Kronenwett, R; Brase, JC; Gnant, M; Austrian Breast and Colorectal Cancer Study Group (ABCSG). EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
Ann Oncol. 2013; 24(3):640-647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Friedrich, C; von Bueren, AO; von Hoff, K; Gerber, NU; Ottensmeier, H; Deinlein, F; Benesch, M; Kwiecien, R; Pietsch, T; Warmuth-Metz, M; Faldum, A; Kuehl, J; Kortmann, RD; Rutkowski, S Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
Neuro Oncol. 2013; 15(2):224-234 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Greimel, E; Kristensen, GB; van der Burg, ME; Coronado, P; Rustin, G; del Rio, AS; Reed, NS; Nordal, RR; Coens, C; Vergote, I; European Organization for Research and Treatment of Cancer - Gynaecological Cancer Group and NCIC Clinical Trials Group Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy.
Gynecol Oncol. 2013; 131(2):437-444
Web of Science PubMed FullText FullText_MUG

 

Keil, F; Selzer, E; Berghold, A; Reinisch, S; Kapp, KS; De Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsäßer, W; Kainz, H; Riedl, R; Kopp, M; Kornek, G Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
Eur J Cancer. 2013; 49(2):352-359
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum